Phosphate nosawoti

-Delile

• Iyasebenza ku ...
• Cishe iyasebenza ...
• Kungenzeka kusebenze ...
• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

Usawoti we-phosphate ubhekisa ezinhlanganisweni eziningi ezahlukahlukene ze-phosphate yamakhemikhali nosawoti namaminerali. Ukudla okuphezulu kwi-phosphate kufaka phakathi imikhiqizo yobisi, okusanhlamvu okuphelele, amantongomane, nenyama ethile. Ama-Phosphates atholakala emikhiqizweni yobisi nenyama kubonakala sengathi amuncwa kalula umzimba kunama-phosphates atholakala ezinhlamvini zokusanhlamvu. Iziphuzo zeCola ziqukethe i-phosphate eningi - kakhulu, empeleni, ukuthi zingadala i-phosphate eningi egazini.

Abantu basebenzisa usawoti we-phosphate ekwenzeni umuthi. Qaphela ukuthi ungadidanisi usawoti we-phosphate nezinto ezifana ne-organophosphates, enobuthi kakhulu.

Usawoti we-Phosphate uvame ukusetshenziselwa ukuhlanza amathumbu, amazinga aphansi egazi e-phosphate, ukuqunjelwa, amazinga aphezulu egazi e-calcium, nesilungulela.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze PHOSPHATE SALTS zimi kanje:

Iyasebenza ku ...

• Ukulungisa isisu senqubo yokwelashwa. Ukuthatha imikhiqizo ye-sodium phosphate ngomlomo ngaphambi kwenqubo ye-colonoscopy kuyasebenza ekuhlanzweni kwamathumbu. Eminye imikhiqizo ye-sodium phosphate (OsmoPrep, Salix Pharmaceuticals; Visicol, Salix Pharmaceuticals) ivunywa yi-US Food and Drug Administration (FDA) ngalokhu. Kodwa-ke, ukuthatha i-sodium phosphate kungakhuphula ingozi yokulimala kwezinso kwabanye abantu. Ngalesi sizathu, imikhiqizo ye-sodium phosphate ayisasetshenziswa kakhulu e-U.S. Ukulungiselela amathumbu.
• Amazinga aphansi e-phosphate egazini. Ukuthatha i-sodium noma i-potassium phosphate ngomlomo kuyasebenza ekuvimbeleni noma ekwelapheni amazinga aphansi e-phosphate egazini. Usawoti we-phosphate ongangena ngaphakathi ungaphatha namazinga aphansi e-phosphate egazini lapho esetshenziswa ngaphansi kokuqondisa kukadokotela.

Cishe iyasebenza ...

• Ukuqunjelwa. I-sodium phosphate iyisithako se-FDA-allowed over-the-counter (OTC) ekwelapheni ukuqunjelwa. Le mikhiqizo ithathwa ngomlomo noma isetshenziswe njenge-enemas.
• Ukugaya ukudla. I-Aluminium phosphate ne-calcium phosphate yizithako ezivunyelwe i-FDA ezisetshenziswa kuma-antacids.
• Amazinga aphezulu e-calcium egazini. Ukuthatha usawoti we-phosphate (ngaphandle kwe-calcium phosphate) ngomlomo kungenzeka kuphumelele ekwelapheni amazinga aphezulu we-calcium egazini. Kepha usawoti we-phosphate emithanjeni akufanele usetshenziswe.

Kungenzeka kusebenze ...

• Amatshe ezinso (nephrolithiasis). Ukuthatha i-potassium phosphate ngomlomo kungasiza ekuvimbeleni amatshe ezinso ze-calcium ukuthi angakheki ezigulini ezinamazinga aphezulu omchamo we-calcium.

Ubufakazi obanele bokukala ukusebenza kwe ...

• Ukusebenza kwezemidlalo. Olunye ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-sodium phosphate ngomlomo izinsuku eziyi-6 ngaphambi kokuhamba ngamandla ngebhayisikili noma ukuphrinta kungathuthukisa ukusebenza kwezemidlalo. Kepha olunye ucwaningo lwakuqala alukhombisi nzuzo. Kudingeka izifundo eziningi emaqenjini amakhulu abantu ukubona ukuthi i-sodium phosphate iyasiza ngempela. Ukuthatha amanye usawoti we-phosphate njenge-calcium phosphate noma i-potassium phosphate akuthuthukisi ukusebenza kokugijima noma ukuhamba ngebhayisikili.
• Inkinga yesifo sikashukela (ketoacidosis yesifo sikashukela). Ucwaningo lwakuqala lukhombisa ukuthi ukunikeza i-potassium phosphate ngemithambo (nge-IV) akwenzi ngcono inkinga yesifo sikashukela lapho umzimba ukhiqiza khona ama-acid amaningi egazi abizwa ngama-ketone. Abantu abanalesi simo kufanele banikezwe kuphela ama-phosphates uma benamazinga aphansi e-phosphate.
• I-osteoporosis. Ucwaningo lukhombisa ukuthi ukuthatha i-calcium phosphate ngomlomo kusiza ukuthuthukisa ukuminyana kwamathambo okhalweni nokwehla komgogodla kwabesifazane abane-osteoporosis. Kodwa ayisebenzi kangcono kuneminye imithombo ye-calcium, efana ne-calcium carbonate.
• Izinkinga ezenzeka lapho kudliwa kubantu ababekade belamba (refeeding syndrome). Ucwaningo lwakuqala lukhombisa ukuthi ukunikeza i-sodium ne-potassium phosphate ngemithambo yegazi (ngo-IV) ngaphezulu kwamahora angama-24 kuvimbela ukubuyisela emuva i-syndrome uma uqala kabusha umsoco kubantu abangondlekile kakhulu noma abalambile.
• Amazinyo azwelayo.
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala usawoti we-phosphate walokhu kusetshenziswa.

Ama-phosphates ngokuvamile amuncwa ekudleni futhi angamakhemikhali abalulekile emzimbeni. Babandakanyekile ekwakhiweni kweseli, ukuthuthwa kwamandla nokugcinwa, ukusebenza kwamavithamini, nezinye izinqubo eziningi ezibalulekile empilweni. Usawoti we-Phosphate ungasebenza njengama-laxatives ngokubangela uketshezi oluningi ukuthi ludonseke emathunjini futhi luvuselele amathumbu ukuthi akhiphe okuqukethwe kwawo ngokushesha.

Usawoti we-phosphate oqukethe i-sodium, i-potassium, i-aluminium, noma i-calcium CISHE UVIKILE kubantu abaningi lapho bethathwa ngomlomo, bafakwa engxenyeni, noma banikezwa ngemithambo (yi-IV) ngokufanele nangesikhathi esifushane. Usawoti we-phosphate kufanele usetshenziswe kuphela ngaphakathi (nge-IV) ngaphansi kokuqondisa kukadokotela.

Usawoti we-Phosphate (ochazwe njenge-phosphorus) yiwo MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngemithamo ephakeme kunamagremu ama-4 ngosuku kubantu abadala abangaphansi kweminyaka engama-70 kanye no-3 amagremu ngosuku kubantu abadala.

Ukusetshenziswa kwesikhathi eside njalo kungaphazamisa ibhalansi yama-phosphates namanye amakhemikhali emzimbeni futhi kufanele ihlolwe nguchwepheshe wezokunakekelwa kwezempilo ukugwema imiphumela emibi kakhulu. Usawoti we-Phosphate ungacasula umgudu wokugaya ukudla futhi ubangele ukucasuka kwesisu, uhudo, ukuqunjelwa, ikhanda elibuhlungu, ukukhathala nezinye izinkinga.

Ungadidanisi usawoti we-phosphate nezinto ezifana ne-organophosphates, noma ne-tribasic sodium phosphates ne-tribasic potassium phosphates, enobuthi kakhulu.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Usawoti we-phosphate ovela emithonjeni yokudla kukhona CISHE UVIKILE kwabesifazane abakhulelwe noma abancelisayo lapho besetshenziswa kwizibonelelo ezinconywayo zika-1250 mg nsuku zonke komama abaphakathi kweminyaka eyi-14-18 ubudala kanye no-700 mg nsuku zonke kulabo abaneminyaka engaphezu kwengu-18 ubudala. Amanye amanani akhona MHLAWUMBI ANGIPHEPHILE futhi kufanele isetshenziswe kuphela ngezeluleko nokunakekelwa okuqhubekayo kwengcweti kwezempilo.

Izingane: Usawoti we-phosphate CISHE UVIKILE ezinganeni lapho zisetshenziswa kwizibonelelo zansuku zonke ezinconywayo ezingama-460 mg zezingane ezineminyaka engu-1-3 ubudala; 500 mg wezingane ezineminyaka engu-4-8 ubudala; kanye no-1250 mg wezingane ezineminyaka engu-9-18 ubudala. Usawoti we-phosphate MHLAWUMBI ANGIPHEPHILE uma inani le-phosphate elisetshenzisiwe (elivezwe njenge-phosphorus) lidlula ileveli yokubamba engenhla ebekezelelekayo (UL). Ama-UL angama-gramu ama-3 ngosuku ezinganeni ezineminyaka eyi-1-8; kanye no-4 amagremu ngosuku wezingane ezineminyaka engu-9 nangaphezulu.

Isifo senhliziyo: Gwema ukusebenzisa usawoti we-phosphate oqukethe i-sodium uma unesifo senhliziyo.

Ukugcinwa kwamanzi (i-edema): Gwema ukusebenzisa usawoti we-phosphate oqukethe i-sodium uma une-cirrhosis, ukwehluleka kwenhliziyo, noma ezinye izimo ezingadala i-edema.

Izinga eliphakeme le-calcium egazini (hypercalcemia): Sebenzisa usawoti we-phosphate ngokuqapha uma une-hypercalcemia. I-phosphate eningi kakhulu ingadala ukuthi kufakwe i-calcium lapho kungafanele ukuba khona emzimbeni wakho.

Izinga eliphakeme le-phosphate egazini: Abantu abanesifo i-Addison, isifo esibi senhliziyo nesamaphaphu, isifo sezinso, izinkinga ze-thyroid, noma isifo sesibindi kungenzeka kakhulu kunabanye abantu ukuba bahlakulele i-phosphate eningi egazini labo lapho bethatha usawoti we-phosphate. Sebenzisa usawoti we-phosphate kuphela ngezeluleko nokunakekelwa okuqhubekayo kochwepheshe bezokunakekelwa kwezempilo uma unalezi zimo.

Isifo sezinso: Sebenzisa usawoti we-phosphate kuphela ngezeluleko nokunakekelwa okuqhubekayo kochwepheshe bezokunakekelwa kwezempilo uma unezinkinga zezinso.

Maphakathi

Qaphela ngale nhlanganisela.

AmaBisphosphonates

Imithi ye-Bisphosphonate nosawoti we-phosphate kunganciphisa amazinga e-calcium emzimbeni. Ukuthatha amanani amaningi kasawoti we-phosphate kanye nemithi ye-bisphosphonate kungadala ukuthi amazinga e-calcium abe phansi kakhulu.

Amanye ama-bisphosphonates afaka i-alendronate (Fosamax), i-etidronate (i-Didronel), i-risedronate (i-Actonel), i-tiludronate (i-Skelid), nabanye.

I-calcium

I-Phosphate ingahlangana ne-calcium. Lokhu kunciphisa amandla omzimba okuthola i-phosphate ne-calcium. Ukugwema lokhu kuhlangana, i-phosphate kufanele ithathwe okungenani amahora ama-2 ngaphambi noma ngemuva kokuthatha i-calcium.

Insimbi

I-Phosphate ingahlanganiswa nensimbi. Lokhu kunciphisa amandla omzimba okuthola i-phosphate ne-iron. Ukugwema lokhu kuhlangana, i-phosphate kufanele ithathwe okungenani amahora ama-2 ngaphambi noma ngemuva kokuthatha insimbi.

Magnesium

I-Phosphate ingahlanganiswa ne-magnesium. Lokhu kunciphisa amandla omzimba okuthola i-phosphate ne-magnesium. Ukugwema lokhu kuhlangana, i-phosphate kufanele ithathwe okungenani amahora ama-2 ngaphambi noma ngemuva kokuthatha i-magnesium.

Ukudla neziphuzo eziqukethe i-phosphate

Ngokombono, ukuthatha i-phosphate ngokudla neziphuzo eziqukethe i-phosphate kungakhuphula amazinga e-phosphate futhi kwandise ubungozi bemiphumela emibi, ikakhulukazi kubantu abanezinkinga zezinso. Ukudla neziphuzo eziqukethe i-phosphate kufaka phakathi i-cola, iwayini, ubhiya, okusanhlamvu okusanhlamvu okuphelele, amantongomane, imikhiqizo yobisi nokunye kwenyama.

Imithamo elandelayo ifundwe ocwaningweni lwesayensi:

NGOMLOMO:

• Ngokwandisa amazinga e-phosphate aphansi kakhulu: Abahlinzeki bezempilo balinganisa amazinga e-phosphate ne-calcium egazini futhi banikeze i-phosphate eyanele nje ukulungisa inkinga.
• Ukwehlisa amazinga e-calcium aphakeme kakhulu: Abahlinzeki bezempilo balinganisa amazinga e-phosphate ne-calcium egazini futhi banikeze i-phosphate eyanele nje ukulungisa inkinga.
• Ukulungiselela amathumbu inqubo yenqubo yokwelashwa: Izibhebhe ezintathu kuya kwezine zemithi (OsmoPrep, Salix Pharmaceuticals; Visicol, Salix Pharmaceuticals) ngayinye iqukethe u-1.5 gram we-sodium phosphate ithathwa ngama-ounces ayisishiyagalombili amanzi njalo ngemizuzu engu-15 kumaphilisi angama-20 kusihlwa ngaphambi kwe-colonoscopy. Ngakusasa ekuseni, kuthathwa amaphilisi ama-3-4 ngama-ounces ayisishiyagalombili amanzi njalo ngemizuzu engu-15 kuze kuthathwe amaphilisi ayi-12-20.
• Amatshe ezinso (nephrolithiasis): Kusetshenziswe usawoti wePotassium ne-sodium phosphate ohlinzeka ngo-1200-1500 mg we-elemental phosphate nsuku zonke.

NGU-IV:

• Ngokwandisa amazinga e-phosphate aphansi kakhuluKusetshenziswe imikhiqizo efakwa emthanjeni (IV) equkethe i-sodium phosphate noma i-potassium phosphate. Imithamo ye-15-30 mmol inikezwe ngaphezulu kwamahora we-2-12. Imithamo ephakeme isetshenzisiwe uma kudingeka.

Izibonelelo zokudla ezinconywayo zansuku zonke (RDAs) ze-phosphate (ezichazwe njenge-phosphorus) yilezi: Izingane ezineminyaka engu-1-3, 460 mg; izingane iminyaka 4-8, 500 mg; abesilisa nabesifazane iminyaka engu-9-18, 1250 mg; abesilisa nabesifazane abangaphezu kweminyaka engu-18, 700 mg.
Ukufakwa okwanele (AI) kwezinsana yilezi: 100 mg yezinsana ezinezinyanga ezingu-0-6 ubudala kanye no-275 mg wezinsana ezineminyaka engu-7-12 ubudala.
Izinga Lokungenisa Elibekezelelekayo (i-UL), okuyizinga eliphakeme kakhulu lokudla lapho kulindeleke khona imiphumela emibi engafuneki, ngoba i-phosphate (evezwa njenge-phosphorus) ngosuku yilezi: izingane ezineminyaka eyi-1-8, ama-3 amagremu ngosuku; izingane kanye nabantu abadala iminyaka engu-9-70, 4 amagremu; abadala abadala kuneminyaka engama-70, 3 amagremu; abesifazane abakhulelwe iminyaka engu-14-50, 3.5 amagremu; nabesifazane abancelisa ibele iminyaka eyi-14-50, 4 amagremu. Aluminium phosphate, Bone Phosphate, Calcium phosphate, Calcium Orthophosphate, Calcium Phosphate Dibasic Anhydrous, Calcium Phosphate-Bone Ash, Calcium Phosphate Dibasic Dihydrate, Calcium Phosphate Dibasique Anhydre, Calcium Phosphate Dibasique Dihydrate, Calcium Phosphate Difasias, I-Calcium Phosphate Difasi , Di-Calcium Phosphate, Dicalcium Phosphate, Dicalcium Phosphate, Neutral Calcium Phosphate, Orthophosphate de Calcium, Phosphate d'Aluminium, Phosphate de Calcium, Phosphate de Magnésium, Phosphate Neutre de Calcium, Phosphate d'Os, Phosphate Tricalcium, Precipitated Calcium Phosphate, Précipitation du Phosphate de Calcium, Précipité de Phosphate de Calcium, Tertiary Calcium Phosphate, Tricalcium Phosphate, Whitlockite, Magnesium Phosphate, Merisier, Potassium phosphate, Dibasic Potassium Phosphate, Dipotassium Hydrogen Orthophosphate, iDipotassium Monophosphate, i-Phosphate Phosphate Phosphate , I-Potassium Biphosphate, i-Potassium Dihydrogen Orthophosphate, i-Potassium Hydrogen Phosphate, i-Phosphate de Dipotassium, i-Phosphate d'Hydrogène de Potassium, i-Phosphate de Potassium, i-Phosphate de Potassium Dibasique, i-Phosphate de Potassium Monobasique, i-Sodium phosphate, i-Anhydrous Sodium Phosphate, i-Dibasifosidi , Disodium Hydrogen Orthophosphate Dodecahydrate, Disodium Hydrogen Phosphate, Disodium Phosphate, Phosphate of Soda, Sales de Fosfato, Sels de Phosphate, Sodium Orthophosphate, Orthophosphate Disodique d'Hydrogène, Phosphate Disodique d'Hydrogène, Orthophosphate de Sodium, Phosphate deodium, Phosphate deodium de Sodium Dibasique, Phosphorus.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. Amathebulethi e-Visicol Ebeka imininingwane. I-Salix Pharmaceuticals, iRaleigh, NC. Mashi 2013. (https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021097s016lbl.pdf). Kufinyelelwe ngomhla ka-09/28/17.
2. I-Delegge M, i-Kaplan R. Ukusebenza kokulungiswa kwamathumbu kusetshenziswa ukudla okulungiselelwe ngaphambili, okuphansi kwe-fiber nge-sodium ephansi, i-magnesium citrate cathartic vs. i-liquiddiet ecacile ene-sodium phosphate cathartic ejwayelekile. I-Aliment Pharmacol Ther. 2005 Juni 15; 21: 1491-5. Buka okungaqondakali.
3. UJohnson DA, uBarkun AN, uCohen LB, et al .; I-US Multi-Society Task Force ku-Colorectal Cancer. Ukwandisa Ukwanela Kokuhlanzwa Kwamathumbu weColonoscopy: Izincomo Eziqhamuka E-US Multi-Society Task Force on Colorectal Cancer. NginguJ J Gastroenterol 2014; 109: 1528-45. Buka okungaqondakali.
4. Nam SY, Choi IJ, Park KW, Ryu KH, Kim BC, Sohn DK, Nam BH, Kim CG.Ubungozi bokuqaqamba kwesisu okuhambisana nokulungiswa kwamathumbu we-colonoscopy kusetshenziswa isisombululo somlomo se-sodium phosphate. I-Endoscopy. 2010 uFebhu; 42: 109-13. Buka okungaqondakali.
5. U-Ori Y, Rozen-Zvi B, Chagnac A, Herman M, Zingerman B, Atar E, Gafter U, Korzets A. Ukufa kanye nokuphazamiseka okukhulu kwemetabolism okuhambisana nokusetshenziswa kwe-sodium phosphate enemas: isipiliyoni sesikhungo esisodwa. I-Arch Intern Med. 2012 Feb 13; 172: 263-5. Buka okungaqondakali.
6. ILadenhauf HN, iStundner O, iSpreitzhofer F, i-Deluggi S.I-hyperphosphatemia enamandla ngemuva kokuphathwa kwe-sodium-phosphate equkethe ama-laxatives ezinganeni: uchungechunge lwamacala nokubuyekezwa okuhlelekile kwezincwadi. I-Pediatr Surg Int. 2012 Aug; 28: 805-14. Buka okungaqondakali.
7. USchaefer M, uLittrell E, uKhan A, uPatterson ME. Ukulinganiselwa Kokwehla Kwe-GFR Kulandela Izimpawu Ze-Sodium Phosphate Enus Versus Polyethylene Glycol Yokuhlola I-Colonoscopy: Isifundo Seqembu Elibuyiselwayo. Am J Izinso Dis. 2016 Ephreli; 67: 609-16. Buka okungaqondakali.
8. UBrunelli SM. Ukuhlangana phakathi kwamalungiselelo we-sodium phosphate wamathumbu nokulimala kwezinso: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta. Am J Izinso Dis. 2009 Mar; 53: 448-56. Buka okungaqondakali.
9. UChoi NK, Lee J, Chang Y, Kim YJ, Kim JY, Ingoma HJ, Shin JY, Jung SY, Choi Y, Lee JH, Park BJ. Ukwehluleka okukhulu kwezinso kulandela ukulungiswa ngomlomo kwe-sodium phosphate bowel: isifundo sezwe lonke le-case-crossover. I-Endoscopy. 2014 Juni; 46: 465-70. Buka okungaqondakali.
10. UBelsey J, Crosta C, Epstein O, Fischbach W, Layer P, Parente F, Halphen M. Meta-analysis: ukusebenza ngokulingana kwamalungiselelo omlomo wamathumbu we-colonoscopy 1985-2010. I-Aliment Pharmacol Ther. 2012 uJan; 35: 222-37. Buka okungaqondakali.
11. UBelsey J, Crosta C, Epstein O, Fischbach W, Layer P, Parente F, Halphen M. Meta-analysis: ukusebenza kahle kwamathumbu amancane ukulungiselela amathumbu amancane we-capsule endoscopy. I-Curr Med Res Opin. 2012 Dis; 28: 1883-90. Buka okungaqondakali.
12. Czuba M, Zajac A, Poprzecki S, Cholewa J, Woska S. Imiphumela ye-Sodium Phosphate Ukulayishwa ku-Aerobic Power namandla ku-Road Cyclists. J Ezemidlalo Sci Med. 2009 Dec 1; 8: 591-9. Buka okungaqondakali.
13. IBrewer CP, uDawson B, uWallman KE, uGuelfi KJ. Umphumela wokuphindaphindwa kokulayishwa kwe-sodium phosphate ekusebenzeni kwamabhayisikili ngesikhathi sokulingwa naku-VO2peak. Int J Ezemidlalo Umzimba Wokuzivocavoca umzimba. 2013 Ephreli; 23: 187-94. Buka okungaqondakali.
14. UBuck CL, uWallman KE, uDawson B, uGuelfi KJ. I-sodium phosphate njengosizo lwe-ergogenic. Ezemidlalo Med. 2013 Juni; 43: 425-35. Buka okungaqondakali.
15. UBuck CL, uDawson B, uGuelfi KJ, uMcNaughton L, uWallman KE. Ukuxhaswa kwe-sodium phosphate nokusebenza kwecala lesikhathi kubagibeli bamabhayisikili besifazane. J Ezemidlalo Sci Med. 2014 Septhemba 1; 13: 469-75. Buka okungaqondakali.
16. IBrewer CP, uDawson B, uWallman KE, uGuelfi KJ. Umphumela Wokwengezelelwa Kwe-Sodium Phosphate Ekusebenzeni Kwecala Lokuhamba Ngebhayisikili kanye ne-VO2 1 ne-8 Days Post Loading. J Ezemidlalo Sci Med. 2014 Septhemba 1; 13: 529-34. Buka okungaqondakali.
17. INtshonalanga JS, u-Ayton T, uWallman KE, uGuelfi KJ. Umphumela wezinsuku eziyi-6 zokwengezwa kwe-sodium phosphate ekudleni, ekudleni amandla, nasemandleni e-aerobic emadodeni nakwabesifazane abaqeqeshiwe. Int J Ezemidlalo Umzimba Wokuzivocavoca umzimba. 2012 Dis; 22: 422-9. Buka okungaqondakali.
18. van Vugt van Pinxteren MW, van Kouwen MC, van Oijen MG, van Achterberg T, Nagengast FM. Ukufundwa okulindelwe kokulungiswa kwamathumbu kwe-colonoscopy ngesisombululo se-polyethylene glycol-electrolyte kuqhathaniswa ne-sodium phosphate eLynch syndrome: isilingo esingahleliwe. Umdlavuza we-Fam. 2012 Septhemba; 11: 337-41. Buka okungaqondakali.
19. U-Lee SH, u-Lee DJ, uKim KM, u-Seo SW, uKang JK, u-Lee EH, u-Lee DR. Ukuqhathanisa ukusebenza nokuphepha kwamathebulethi e-sodium phosphate nesisombululo se-polyethylene glycol sokuhlanzwa kwamathumbu kubantu abadala baseKorea abanempilo. UYonsei Med J. 2014 Nov; 55: 1542-55. Buka okungaqondakali.
20. UKopec BJ, uDawson BT, uBuck C, uWallman KE. Imiphumela ye-sodium phosphate ne-caffeine ukungenisa kumandla okuphindaphindeka kwe-sprint kubadlali besilisa. J Sci Med Ezemidlalo. 2016 Mar; 19: 272-6. Buka okungaqondakali.
21. UJung YS, Lee CK, Kim HJ, Eun CS, Han DS, iPaki DI. Isivivinyo esilawulwa ngokungahleliwe samaphilisi e-sodium phosphate vs solution polyethylene glycol yokuhlanzwa kwamathumbu we-colonoscopy. Umhlaba J Gastroenterol. 2014 Novemba 14; 20: 15845-51. Buka okungaqondakali.
22. UHeaney RP, uRecker RR, uWatson P, uLappe JM. I-phosphate ne-carbonate usawoti we-calcium osekela ukwakhiwa kwamathambo okuqinile e-osteoporosis. Ngingu-J J Nutriti Womtholampilo. 2010 Julayi; 92: 101-5. Buka okungaqondakali.
23. U-Ell C, uFischbach W, Layer P, uHalphen M. Isivivinyo esingahleliwe, esilawulwayo se-2 L polyethylene glycol kanye nezinto ze-ascorbate uma kuqhathaniswa ne-sodium phosphate yokuhlanzwa kwamathumbu ngaphambi kwe-colonoscopy yokuhlolwa umdlavuza. I-Curr Med Res Opin. 2014 Dis; 30: 2493-503. Buka okungaqondakali.
24. UBuck CL, uHenry T, uGuelfi K, uDawson B, uMcNaughton LR, uWallman K. Imiphumela ye-sodium phosphate ne-beetroot juice supplementation ekhonweni lokuphindaphinda kwabesifazane. I-Eur J Appl Physiol. 2015 Okthoba; 115: 2205-13. Buka okungaqondakali.
25. UBuck C, uGuelfi K, uDawson B, uMcNaughton L, uWallman K. Imiphumela ye-sodium phosphate nokulayishwa kwe-caffeine kumandla we-Sprint Sprint. J Ezemidlalo Sci. 2015; 33: 1971-9. Buka okungaqondakali.
26. IBrewer CP, uDawson B, uWallman KE, uGuelfi KJ. Umphumela wesengezo se-sodium phosphate kwimizamo ephindaphindwayo yamabhayisikili aphezulu. J Ezemidlalo Sci. 2015; 33: 1109-16. Buka okungaqondakali.
27. UFolland, JP, Stern, R, noBrickley, G. Ukulayishwa kwe-phosphate yesodium kuthuthukisa ukusebenza kwelabhayisikili ngesikhathi sokulingwa kwabagibeli bamabhayisikili abaqeqeshiwe. UJ Sci Med Ezemidlalo 2008; 11: 464-8. Buka okungaqondakali.
28. UFisher, JN noKitabchi, AE. Ucwaningo olwenziwe ngokungahleliwe lokwelashwa kwe-phosphate ekwelapheni i-ketoacidosis yesifo sikashukela. UJ Clin Endocrinol Metab 1983; 57: 177-80. Buka okungaqondakali.
29. UTerlevich A, Ukuzwa i-SD, iWoltersdorf WW, et al. I-Refeeding syndrome: ukwelashwa okusebenzayo futhi okuphephile nge-Phosphates Polyfusor. I-Aliment Pharmacol Ther 2003; 17: 1325-9. Buka okungaqondakali.
30. USavica, V, Calo, LA, uMonardo, P, et al. I-salivary phosphorus ne-phosphate okuqukethwe kweziphuzo: imiphumela yokwelashwa kwe-uremic hyperphosphatemia. UJ Ren Nutriti 2009; 19: 69-72. Buka okungaqondakali.
31. UHu, S, Shearer, GC, Steffes, MW, Harris, WS, noBostom, AG. I-niacin ekhishwa kanye ngosuku ekhishwa nsuku zonke yehlisa ukugxila kwe-serum phosphorus ezigulini ezinesifo se-metabolic syndrome dyslipidemia. NginguJ J Kidney Dis 2011; 57: 181-2. Buka okungaqondakali.
32. ISchaiff, i-RA, iHholo, i-TG, ne-Bar, i-RS. Ukwelashwa kwe-hypercalcemia. IClin Pharm 1989; 8: 108-21. Buka okungaqondakali.
33. Elliott, GT noMcKenzie, MW. Ukwelashwa kwe-hypercalcemia. Izidakamizwa Intell Clin Pharm 1983; 17: 12-22. Buka okungaqondakali.
34. UBugg, NC noJones, JA. I-Hypophosphataemia. I-Pathophysiology, imiphumela kanye nokuphathwa egumbini labagula kakhulu. I-Anesthesia 1998; 53: 895-902. Buka okungaqondakali.
35. OsmoPrep Ukunikeza imininingwane. I-Salix Pharmaceuticals, iRaleigh, NC. Okthoba 2012. (http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021892s006lbl.pdf, kufinyelelwe ku-02/24/15).
36. Uhlu lwezithako ze-FDA OTC, Ephreli 2010. Lutholakala ku: www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM135691.pdf (kufinyelelwe ku-2/7/15).
37. UFinkelstein JS, uKlibanski A, u-Arnold AL, et al. Ukuvimbela ukulahleka kwethambo okuhlobene nokushoda kwe-estrogen ngehomoni yomuntu eyi-parathyroid- (1-34): isilingo esilawulwa ngokungahleliwe. I-JAMA 1998; 280: 1067-73. Buka okungaqondakali.
38. Winer KK, Ko CW, Reynolds JC, et al. Ukwelashwa kwesikhathi eside kwe-hypoparathyroidism: Ucwaningo olulawulwa ngokungahleliwe ngokuqhathanisa i-hormone ye-parathyroid (1-34) ne-calcitriol ne-calcium. UJ Clin Endocrinol Metab 2003; 88: 4214-20. Buka okungaqondakali.
39. ULindsay R, uNieves J, uFormica C, et al. Ucwaningo olulawulwa ngokungahleliwe lomphumela we-hormone ye-parathyroid ku-vertebral-bone mass kanye ne-fracture izehlakalo phakathi kwabesifazane be-postmenopausal ku-estrogen abane-osteoporosis. ILancet 1997; 350: 550-5. Buka okungaqondakali.
40. Winer KK, Yanovski JA, Cutler GB Jr. Synthetic human parathyroid hormone 1-34 vs calcitriol ne calcium ekwelapheni i-hypoparathyroidism. I-JAMA 1996; 276: 631-6. Buka okungaqondakali.
41. I-Leung AC, i-Henderson IS, i-Holo DJ, uDobbie JW. I-Aluminium hydroxide iqhathaniswa ne-sucralfate njengesibopho se-phosphate ku-uraemia. UBr Med J (Clin Res Ed) 1983; 286: 1379-81. Buka okungaqondakali.
42. Roxe DM, Mistovich M, Barch DH. Imiphumela ebopha i-phosphate ye-sucralfate ezigulini ezinokwehluleka kwezinso okungapheli. NginguJ J Kidney Dis 1989; 13: 194-9. Buka okungaqondakali.
43. UHergesell O, Ritz E. Phosphate binders ngesisekelo sensimbi: umbono omusha? Izinso Intl Suppl 1999; 73: S42-5. Buka okungaqondakali.
44. UPeter T, Apt L, uRoss JF. Umphumela wama-phosphates ekufakeni i-iron okufundwe ezifundweni ezijwayelekile zabantu nakwimodeli yokuhlola kusetshenziswa i-dialysis. I-Gastroenterology 1971; 61: 315-22. Buka okungaqondakali.
45. UMonsen ER, Cook JD. Ukufakwa kwensimbi yokudla ezifundweni zabantu IV. Imiphumela ye-calcium nosawoti we-phosphate ekumungeni i-nonheme iron. Ngingu-J J Nutriti 1976; 29: 1142-8. Buka okungaqondakali.
46. ULindsay R, uNieves J, uHenneman E, et al. Ukuphathwa okungaphansi kwesicucu se-amino-terminal se-hormone yomuntu e-parathyroid- (1-34): i-kinetics nempendulo yamakhemikhali ezigulini ze-osteoporotic ze-estrogenized. UJ Clin Endocrinol Metab 1993; 77: 1535-9. Buka okungaqondakali.
47. UCampisi P, uBadhwar V, uMorin S, uTrudel JL. I-postoperative hypocalcemic tetany ebangelwe ukulungiselela iFleet Phospho-Soda esigulini esithatha i-alendronate sodium. IDis Colon Rectum 1999; 42: 1499-501. Buka okungaqondakali.
48. I-Loghman-Adham M. Ukuphepha kwama-phosphate binders amasha okwehluleka kwezinso okungamahlalakhona. Izidakamizwa Saf 2003; 26: 1093-115. Buka okungaqondakali.
49. USchiller LR, uSanta Ana CA, uSheikh MS, et al. Umphumela wesikhathi sokuphathwa kwe-calcium acetate ku-phosphorus binding. Okusha Engl J Med 1989; 320: 1110-3. Buka okungaqondakali.
50. I-Saadeh G, i-Bauer T, i-Licata A, i-Sheeler L. i-Antacid eyenziwe nge-osteomalacia. ICleve Clin J Med 1987; 54: 214-6. Buka okungaqondakali.
51. UGregory JF. Ukutadisha okwenzeka: ukutholakala kwe-folate. J Izakhi 2001; 131: 1376S-1382S. Buka okungaqondakali.
52. Insogna KL, Bordley DR, Caro JF, Lockwood DH. I-Osteomalacia nobuthakathaka bokungenisa ngokweqile kwe-antacid. I-JAMA 1980; 244: 2544-6. Buka okungaqondakali.
53. UHeaney RP, uNordin BE. Imiphumela ye-calcium ekusetshenzisweni kwe-phosphorus: imiphumela yokuvikela nokwelashwa ngokubambisana kwe-osteoporosis. J Am Coll Nutriti 2002; 21: 239-44 .. Buka okungaqondakali.
54. URosen GH, uBoullata JI, O'Ranger EA, et al. Uhlobo lwe-intravenous phosphate repletion regimen lweziguli ezibucayi ezine-hypophosphatemia elinganiselayo. I-Crit Care Med 1995; 23: 1204-10. Buka okungaqondakali.
55. IPerreault MM, i-Ostrop NJ, iTierney MG. Ukusebenza nokuphepha kokufakwa kwe-phosphate emthanjeni ezigulini ezibucayi. U-Ann Pharmacother 1997; 31: 683-8. Buka okungaqondakali.
56. UDuffy DJ, uConlee RK. Imiphumela yokulayishwa kwe-phosphate emandleni omlenze nokuvivinya umzimba ngamandla. IMed Sci Sports Exerc 1986; 18: 674-7. Buka okungaqondakali.
57. IBhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha. Ukufakwa Kwezithenjwa Zezokudla KweCalcium, Phosphorus, Magnesium, Vitamin D, neFluoride. Washington, DC: National Academy Press, 1999. Itholakala ku: http://books.nap.edu/books/0309063507/html/index.html.
58. UCarey CF, uLee HH, uWoeltje KF (ama-eds). Umbhalo WaseWashington Wezokwelapha. Umhla ka-29. ENew York, NY: Lippincott-Raven, 1998.
59. I-Alvarez-Arroyo MV, iTraba ML, iRapado TA, et al. Ukuhlangana phakathi kwamazinga we-1.25 dihydroxyvitamin D serum kanye nezinga le-fractional lokufakwa kwe-calcium yamathumbu emathunjini e-hypercalciuric nephrolithiasis. Indima ye-phosphate. I-Urol Res 1992; 20: 96-7. Buka okungaqondakali.
60. UHeaton KW, uLever JV, uBarnard RE. I-Osteomalacia ehlotshaniswa nokwelashwa kwe-cholestyramine yohudo lwe-post-ileectomy. I-Gastroenterology 1972; 62: 642-6. Buka okungaqondakali.
61. I-Becker GL. Icala elibhekene no-oyela wamaminerali. NginguJ J Digestive Dis 1952; 19: 344-8. Buka okungaqondakali.
62. USchwarz KB, uGoldstein PD, uWitztum JL, et al. Ukugxila kwamavithamini ancibilika emzimbeni ezinganeni ezine-hypercholestrolemic eziphathwe nge-colestipol. Izifo zezingane 1980; 65: 243-50. Buka okungaqondakali.
63. INtshonalanga RJ, uLloyd JK. Umphumela we-cholestyramine ekumungeni kwamathumbu. Amathambo 1975; 16: 93-8. Buka okungaqondakali.
64. USpencer H, Menaham L. Imiphumela emibi yama-antacids aqukethe i-aluminium ku-metabolism yemaminerali. I-Gastroenterology 1979; 76: 603-6. Buka okungaqondakali.
65. URoberts DH, uKnox FG. Ukuphathwa kwe-renal phosphate ne-calcium nephrolithiasis: indima ye-phosphate yokudla kanye nokuvuza kwe-phosphate. USemin Nephrol 1990; 10: 24-30. Buka okungaqondakali.
66. UHarmelin DL, uMartin FR, uWark JD. I-Antacid-induced phosphate depletion syndrome eyethula njenge-nephrolithiasis. U-Aust NZ J Med 1990; 20: 803-5. Buka okungaqondakali.
67. I-Yates AA, iSchlicker SA, iSuitor CW. Ukufakwa kwereferensi yokudla: Isisekelo esisha sezincomo ze-calcium nezakhi ezihlobene, amavithamini B, ne-choline. J Am Ukudla Assoc 1998; 98: 699-706. Buka okungaqondakali.
68. UFauci AS, uBraunwald E, u-Isselbacher KJ, et al. Izimiso zikaHarrison zeMithi Yangaphakathi, ngomhla ka-14. ENew York, NY: McGraw-Hill, 1998.
69. I-Shils ME, u-Olson JA, uShike M, uRoss AC, ama-eds. Ukondleka Kwamanje Ezempilo Nezifo. Umhlaka 9. IBaltimore, MD: Williams & Wilkins, 1999.
70. IGalloway SD, iTremblay MS, iSexsmith JR, uRoberts CJ. Imiphumela ye-acute phosphate supplementation ezifundweni zamazinga ahlukene wokuqina kwe-aerobic. I-Eur J Appl Physiol Umsebenzi wePhysiol 1996; 72: 224-30. Buka okungaqondakali.
71. UHelikson MA, uParham WA, uTobias JD. I-Hypocalcemia ne-hyperphosphatemia ngemuva kokusetshenziswa kwe-enema ye-phosphate enganeni. UJ Pediatr Surg 1997; 32: 1244-6. Buka okungaqondakali.
72. UDiPalma JA, uBuckley SE, uWarner BA, et al. Imiphumela yamakhemikhali e-sodium phosphate yomlomo. I-Dig Dis Sci 1996; 41: 749-53. Buka okungaqondakali.
73. UFine A, uPatterson J. I-hyperphosphatemia enamandla elandela ukuphathwa kwe-phosphate yokulungiselela amathumbu ezigulini ezinokwehluleka kwezinso: amacala amabili nokubuyekezwa kwezincwadi. Am J Izinso Dis 1997; 29: 103-5. Buka okungaqondakali.
74. UClarkston WK, uTsen TN, uDies DF, et al. Isixazululo somlomo se-sodium phosphate kuqhathaniswa ne-sulphate-free polyethylene glycol electrolyte lavage ekulungiseleleni iziguli ezingaphandle kwe-colonoscopy: ukuqhathanisa okulindelekile. UGastrointest Endosc 1996; 43: 42-8. Buka okungaqondakali.
75. IHill AG, Teo W, Still A, et al. Ukuncipha kwe-potassium yeselula kubeka ku-hypokalaemia ngemuva komlomo we-sodium phosphate. U-Aust N Z J Surg. 1998; 68: 856-8. Buka okungaqondakali.
76. Umsizi HJ, Reza-Albarran AA, Breslau NA, Pak CY. Ukwehliswa okusimeme kwe-calcium yomchamo ngesikhathi sokwelashwa kwesikhathi eside ngokukhishwa okuhamba kancane kwe-potassium phosphate ku-hypercalciuria. UJ Urol 1998; 159: 1451-5; ingxoxo 1455-6. Buka okungaqondakali.
77. UHardman JG, uLimbird LL, uMolinoff PB, ama-eds. UGoodman noGillman’s The Pharmacological Basis of Therapeutics, umhla ka-9. ENew York, NY: McGraw-Hill, 1996.
78. I-DS encane. Imiphumela Yezidakamizwa Ekuvivinyweni Kwelabhoratri Yomtholampilo 4th ed. IWashington: I-AACC Press, 1995.
79. UMcEvoy GK, umhleli. Imininingwane Yezidakamizwa ze-AHFS. I-Bethesda, MD: I-American Society of Health-System Pharmacists, ngo-1998.
80. Ama-monographs ngokusetshenziswa kokwelashwa kwemithi yezitshalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.

Kugcine ukubuyekezwa - 01/29/2019